0
0
A groundbreaking study presented at the 2025 European Association of Nuclear Medicine Congress reveals that not just the amount but the metabolic activity of belly fat, especially visceral fat around internal organs, is strongly linked to aggressive endometrial cancer in women. This discovery could transform cancer risk assessment and prevention strategies, highlighting the importance of managing deep belly fat for women’s health.
Metabolically Active Belly Fat and Cancer Risk
Recent research led by Haukeland University Hospital and the University of Bergen analyzed PET/CT scans of 274 women diagnosed with endometrial cancer, the most common cancer of the uterine lining. Scientists measured glucose uptake in visceral fat, an indicator of its metabolic activity, finding that higher metabolic activity—not just volume—of this deep belly fat significantly correlates with advanced cancer stages and lymph node metastases.
Lead author Jostein Sæterstøl, PhD candidate, explained, “We saw no strong correlation between the volume of visceral fat and its metabolic activity, suggesting disease aggressiveness is tied more to biological activity of the fat than to its quantity.” This presents a shift in understanding obesity-related cancer risks, focusing attention on fat behavior, not just fat accumulation.
Context: Obesity, Fat Distribution, and Cancer
Obesity is a well-known risk factor for multiple cancers, particularly breast, endometrial (uterine), colorectal, and esophageal cancers. However, the links differ by fat distribution. Studies show that abdominal fat has a greater impact on cancer risk than fat deposited around hips and thighs, with visceral fat being metabolically active and promoting inflammation and metabolic changes conducive to cancer development.
One 2025 study also noted increased risks for three cancers—endometrial, esophageal, and liver cancer—linked specifically to belly fat. On the other hand, fat stored in the lower body (buttock and thighs) may have protective effects against some cancers like breast cancer.
Expert Perspectives
Dr. Charles L. Shapiro, a breast cancer specialist at Mount Sinai Health System, who was not involved in the study, highlighted the importance of these findings: “It stands to reason that if you have metabolically active fat, regardless of your overall weight or BMI, you may have a higher cancer risk. This research provides a new wrinkle in understanding how body fat influences cancer.”
Obesity researcher Dr. Landau emphasized, “BMI is a quick and dirty health marker. Fat location and metabolic activity are crucial for assessing health risks, not just sheer fat amount”.
Why Belly Fat Matters More
Visceral fat differs from subcutaneous fat by surrounding internal organs and being highly metabolically active. It influences hormone production, immune responses, and inflammation—all pathways implicated in cancer development and progression. This fat “crosstalk” with cancer cells may encourage aggressive tumor growth and metastasis.
Unlike older views focusing solely on body weight or waist circumference, assessing metabolic activity via imaging advances the ability to predict cancer aggressiveness, paving the way for personalized risk evaluation and targeted therapies related to fat metabolism.
Public Health Implications
With obesity and endometrial cancer rates rising globally, understanding how visceral fat behaves can guide preventive strategies. Lifestyle interventions aimed at reducing visceral fat through diet, exercise, and possibly pharmacological options may offer cancer risk reduction beyond numbers on a scale.
This research encourages clinicians to consider visceral fat metabolic activity when assessing cancer risk and treatment responses. Future developments in diagnostic imaging and drugs to “cool down” metabolically active fat could transform care for women at risk of aggressive cancers.
Limitations and Balanced View
While findings are compelling, the research is observational and based on a specific cohort of women with endometrial cancer. Larger, diverse population studies are needed to generalize results. Also, the metabolic activity measurement requires advanced imaging, not yet routine in cancer screening.
It remains critical for public health messaging to avoid simplifications; not all fat is harmful equally, and body mass alone is insufficient for judgment. Conflicting effects of fat distribution on different cancer types remind us of the complexity surrounding adiposity and disease risk.
Practical Takeaways for Readers
-
Belly fat, especially visceral fat, is more than just fat—it’s metabolically active tissue that may fuel cancer progression.
-
Maintaining a healthy lifestyle with physical activity and balanced nutrition is key to controlling visceral fat.
-
Body weight and BMI don’t tell the full story; fat distribution and metabolic health deserve attention for cancer prevention.
-
Women, particularly postmenopausal, should discuss personalized risk assessments with their healthcare providers, potentially including imaging advancements.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
